Read the latest positive news, breakthroughs, and inspiring stories about cell therapy, curated daily by BrightWire.
Australian researchers have cracked a major problem in cell therapy by turning everyday hospital drugs into precision control dials for engineered immune cells. The breakthrough could help thousands of patients who need both lifesaving cell treatments and ongoing immune suppression.
A Gurugram company is developing cancer treatments that can be made in advance and stored, potentially making cutting-edge cell therapy available to more patients at lower costs. East Ocyon Bio just raised $4.2 million to move toward human trials of its made-in-India approach.
Scientists at Johns Hopkins Medicine developed a magnetic imaging technique that lets them watch therapeutic cells travel through the body, potentially revolutionizing how doctors personalize cancer and autoimmune treatments. The breakthrough could help ensure every patient gets exactly the right dose delivered to the right place.
Scientists can now watch cell therapies travel through the body, potentially making treatments for cancer and autoimmune diseases more effective. This breakthrough could help doctors personalize dosing for each patient.
A breakthrough cell therapy cut the death rate in half for patients with advanced liver disease, offering hope beyond transplants. After four years, 70% of patients treated were alive without needing a transplant, compared to just 40% who received standard care.
A rice-sized implant with living cells is now FDA-approved to slow vision loss in MacTel patients, offering hope to thousands losing their sight. For the first time, people with this rare retinal disease have a real chance to preserve their independence.
A groundbreaking quality certification for cutting-edge immune cell therapies just passed its first inspection, opening the door for safer treatment expansion beyond cancer into autoimmune diseases. The framework ensures patients receive consistent, high-quality care as these life-changing therapies reach more people.
A breakthrough study shows promise for liver transplant recipients to accept new organs without harsh lifelong medications. Scientists used special immune cells from donors to train patients' bodies to recognize transplanted livers as their own.
A small trial shows immune cells from liver donors can teach recipients' bodies to accept new organs without harsh medication. The breakthrough could end transplant patients' lifelong dependence on drugs that weaken immunity and cause serious side effects.
A California biotech company just launched a groundbreaking program to create lab-grown corneal cells that could help 300 million people worldwide facing blindness from a degenerative eye disease. The treatment could solve a devastating shortage where only one donor cornea exists for every 70 patients who need one.
Scientists have successfully reversed heart failure damage using engineered immune cells, offering hope to millions. The therapy reduced scarring and restored heart function in both animal and primate studies without harmful side effects.
AstraZeneca is partnering with robotics company Multiply Labs to automate the complex process of making cell therapies, potentially making these breakthrough treatments accessible to more patients. The collaboration could transform how these powerful medicines reach people who need them.